- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT01796639
Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China (REACH)
The primary objective of this study is to evaluate graft survival and recipient survival among kidney transplant recipients in China, and also to analyze possible factors related to patient and graft survival.
The secondary objective is to evaluate several secondary outcomes among kidney transplant recipients, such as average creatinine value, acute rejection episodes, NODM, incidence of BKV infection etc. At the same time analyze possible impact factors related to these secondary outcomes.
Przegląd badań
Status
Warunki
Szczegółowy opis
Renal transplantation is the choice for patients with end-stage renal disease. In the past two decades, progress in surgical procedure, medical care, and immunosuppression have significantly improved the short-term results of organ transplantation. Nevertheless, grafts continue to fail over time, these improvements in immunosuppression and reduced incidence of acute rejection episodes have had only minimal effects on chronic allograft dysfunction and late graft loss. Long-term patient's death and graft failure are the main limitations for a better performance of renal transplant programs.
Multiple factors have been shown to affect the outcome of renal transplantation. These include demographic characteristics such as race and ethnicity, pretransplantation dialysis course, the timing of the transplantation,and the patients' co morbidities. Patient response to the transplantation procedure (e.g., delayed graft function, acute rejection, and acute tubular necrosis) is strongly associated with the long-term prognosis. In the last decade, with the increase of immunosuppressive agents in our therapeutic arsenal, several attempts have been made to improve graft performance. However, the majority of trials aiming to avoid calcineurin inhibitor (CNI)-related nephrotoxicity only reported short-term data. Also, and because of the lack of assessment of the role of the different ethiopathogenic factors that lead to graft damage, just avoiding CNI-related nephrotoxicity may be an oversimplification of the problem in the prevention of graft attrition.
There are many studies which have evaluated the long-term outcomes of graft and patient survival and have analyzed multiple relative factors. Unfortunately, such data in Chinese population are lacking. Meanwhile, the situation in China is somewhat different with others, such as race, the dosage of immunosuppressant and so on. A better characterization of the weight of immune and non-immune factors responsible for graft damage may help us to improve the outcomes in transplant recipients. Studies derived from well-designed and well-performed patient registries can provide a real world view of clinical practice, patient outcomes, safety, and comparative effectiveness and cost effectiveness. The goal of this project is to analyze retrospective data collected by disease registry, then to evaluate the graft and recipient outcomes of kidney transplants and relative impact factors.
Typ studiów
Zapisy (Rzeczywisty)
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Beijing
-
Beijing, Beijing, Chiny, 100034
- Peking University First Hospital
-
Beijing, Beijing, Chiny, 100853
- Chinese PLA General Hospital
-
Beijing, Beijing, Chiny, 100000
- The 309th Hospital of Chinese People's Liberation Army
-
Beijing, Beijing, Chiny, 100020
- Beijing Chaoyang Hospital
-
Beijing, Beijing, Chiny, 100050
- Beijing Friendship Hospital
-
-
Fujian
-
Fuzhou, Fujian, Chiny, 350025
- Fuzhou General hospital of Nanjing Military Command
-
-
Guangdong
-
Guangzhou, Guangdong, Chiny, 510080
- The First Affiliated Hospital Sun Yat-Sen University
-
Guangzhou, Guangdong, Chiny, 510599
- Nanfang Hospital
-
-
Henan
-
Zhengzhou, Henan, Chiny, 450052
- The First Affiliated Hospital of Zhengzhou University
-
-
Hubei
-
Wuhan, Hubei, Chiny, 430030
- Tongji Hospital
-
-
Hunan
-
Changsha, Hunan, Chiny, 410000
- The second Xiangya Hospital of Central South University
-
-
Liaoning
-
Shenyang, Liaoning, Chiny
- Shenyang Military General Hospital
-
-
Shandong
-
Jinan, Shandong, Chiny, 250000
- Jinan Military General Hospital
-
-
Shanghai
-
Shanghai, Shanghai, Chiny, 200032
- Zhongshan Hospital Fudan University
-
Shanghai, Shanghai, Chiny, 200080
- Shanghai First People's Hospital
-
-
Shanxi
-
Xian, Shanxi, Chiny, 710061
- First Affiliated Hospital Of Medical College of Xian Jiaotong University
-
-
Sichuan
-
Chengdu, Sichuan, Chiny, 610041
- West China Hospital,Sichuan University
-
-
Zhejiang
-
Hangzhou, Zhejiang, Chiny, 310003
- The First Affiliated Hospital, Zhejiang University
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Metoda próbkowania
Badana populacja
Opis
Inclusion Criteria:
- Kidney transplant recipients
- Received a transplant from Jan 1,1995 to Dec 31, 2007, only including those with living donor grafts
- Age: 18-75 years
Exclusion Criteria:
- Multiple-organ transplant recipients
- Patients records with missing information in 12 months post-transplantation
- Patients who did not have the information regarding their maintenance immunosuppressive therapy
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Modele obserwacyjne: Kohorta
- Perspektywy czasowe: Z mocą wsteczną
Kohorty i interwencje
Grupa / Kohorta |
---|
kidney transplantation patients with living-donor grafts
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Graft survival
Ramy czasowe: 5-year
|
Graft survival, measured as the time between kidney transplant and the failure of the graft.
|
5-year
|
Recipient survival
Ramy czasowe: 5-year
|
measured as the time between the most recent kidney transplant and the patient's death.
Graft outcome was censored at the earliest of the following events and was analyzed as days to graft failure or censor: loss to follow-up, patient death.
|
5-year
|
Miary wyników drugorzędnych
Miara wyniku |
Ramy czasowe |
---|---|
Average creatinine value
Ramy czasowe: 5 years
|
5 years
|
The rate of acute rejection episodes
Ramy czasowe: 5 years
|
5 years
|
The incidence of BPAR and its severity
Ramy czasowe: 5 years
|
5 years
|
The incidence of NODM
Ramy czasowe: 5 years
|
5 years
|
The incidence of infection
Ramy czasowe: 5 years
|
5 years
|
The incidence of biopsy proven CNIs nephrotoxicity
Ramy czasowe: 5 years
|
5 years
|
The rate of posttransplantation malignancies
Ramy czasowe: 5 years
|
5 years
|
Współpracownicy i badacze
Sponsor
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Oszacować)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Inne numery identyfikacyjne badania
- COLO400ACN02
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
produkt wyprodukowany i wyeksportowany z USA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .